SGHT 8-K SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

SGHT ▲ +12.50% at T+20d

LONG call ✓ call won +12.50% · α vs SPY +7.87% · entry $4.32 → $4.86

Next anchor: T+60d in 6w

Currently $4.85 · +12.27% from $4.32 entry

Entry anchored
Apr 22, 03:59 PM ET
via Databento tick

T+1d

+0.93%

call +0.93% · α +0.14%

$4.36

settled 7w ago

T+5d

-8.10%

call -8.10% · α -9.58%

$3.97

settled 6w ago

T+20d

+12.50%

call +12.50% · α +7.87%

$4.86

settled 20d ago

T+60d

—

call — · α —

—

in 6w

Price Chart

Loading chart...

Executive Summary

Sight Sciences (SGHT) announced a final court judgment in its patent infringement lawsuit against Alcon, awarding the company $55.4 million in damages and a 10% ongoing royalty on Alcon's Hydrus Microstent sales. The award includes past damages, supplemental damages, and interest, but remains subject to appeal.

Actionable Insight

The $55.4 million award and 10% royalty represent a significant near-term financial boost and validation of Sight Sciences' IP, but traders should monitor for potential appeal by Alcon which could delay or alter the outcome. Consider the royalty stream as a new recurring revenue component if the judgment is upheld.

Key Facts

U.S. District Court awarded Sight Sciences $55.4 million in damages from Alcon for patent infringement
Award breakdown: $34.0 million in past damages, $14.7 million in supplemental damages, and $6.8 million in interest
Ongoing royalty of 10% of Hydrus Microstent revenue awarded through patent expiration
Final judgment is subject to appeal by Alcon; no payment will be received until appeal process concludes
Court upheld jury's findings that Alcon willfully infringed three of Sight Sciences' patents

Financial Impact

$55.4 million in lump-sum damages plus ongoing 10% royalty on Hydrus Microstent sales

cashrevenueroyalty income

Risk Factors

Alcon has the right to appeal the decision, which could delay or prevent payment
Adverse rulings in parallel ex parte reexamination proceedings could invalidate the patents and affect the judgment

Market Snapshot

Exchange

Nasdaq

Sector

Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001193125-26-171887
Document: 0001193125-26-171887-index-headers.html	0001193125-26-171887
Document: 0001193125-26-171887-index.html	0001193125-26-171887
Document: 0001193125-26-171887.txt	0001193125-26-171887

5 reports for SGHT

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for SGHT — sortable, filterable
	Type				Now
Apr 23, 2026 6w ago	8-K BULLISH ★ 8/10	$4.32 $4.86	▲ +12.50%	▲ +7.87%	$4.85 (+12.27%)
Apr 21, 2026 7w ago	Press Release NEUTRAL ★ 3/10	$4.27 $4.72	▲ +10.54%	▲ +7.37%	$4.85 (+13.58%)
Apr 1, 2026 10w ago	Insider Cluster BEARISH ★ 5/10	$3.66 $3.97	▼ −8.47%	▲ +1.25%	$4.85 (−32.51%)
Mar 4, 2026 13w ago	8-K MIXED ★ 6/10	$3.96 $3.52	▼ −11.11%	▼ −7.32%	$4.85 (+22.47%)
Mar 4, 2026 13w ago	Press Release MIXED ★ 6/10	$3.96 $3.52	▼ −11.11%	▼ −7.32%	$4.85 (+22.47%)

US Market Status

Market Closed — Opens Thu (11h 15m)

Related Tickers

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access